LCMV infection has been shown to induce a relatively strong T-helper response (at least in C57BL/6 mice) focused almost entirely upon two epitopes, GP61–80 and NP309–328, both of which are presented by I-Ab. The LCMV 61-80 peptide acts preferentially as an LCMV T helper epitope and this epitope seems to be processed differently (lysosomal-independent pathway) for viral cell-mediated targeting.
CAT No: V14005
Synonyms/Alias:LCMV GP (61-80);232598-19-5;AKOS040757558;DA-54828;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.